Skip to content

Recall watch for the stuff you own · As an Amazon Associate we earn from qualifying purchases · Some links earn a commissionDisclosure

ConsumerSun

FDAFDA recall D-0870-2026 · Sep 30, 2026

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company: Clear Eyes Redness Relief recall

Recall found

Answer

Yes, Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15 is recalled as of Sep 30, 2026. On Sep 30, 2026, FDA announced recall D-0870-2026 covering 2,356,248 bottles. What to do: follow the official FDA notice. Last checked Nov 17, 2026, 1:52 PM EST.

Product

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

Reason for recall

Lack of Assurance of Sterility

What to do

FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.

Recall facts
Units2,356,248 bottles
Lot, UPC, model, or componentLot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27
DistributionNationwide in the USA.
Recall dateSep 30, 2026
ClassClass II
Agency IDD-0870-2026
Official noticeU.S. Food and Drug Administration (FDA) enforcement report
Data as of, last checkedNov 17, 2026, 1:52 PM EST

Recall details

FDA classification
Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Status
Ongoing
Codes, lots and dates
Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27; RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27; RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27; RL25N01, RL25N02, RL25N04, Exp. Date Nov-27.
Quantity
2,356,248 bottles
Distribution
Nationwide in the USA.
Recalling firm
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY
Voluntary or mandated
Voluntary: Firm initiated
Recall started
2026-09-15

Source: openFDA enforcement record D-0870-2026 · search recall number D-0870-2026 in FDA's Enforcement Report.

Copied from the agency record without changes. Data as of Nov 17, 2026, 1:52 PM EST. The agency notice is the final word.

Questions

Can I get a refund?

Only if the official notice says so. Follow the remedy on this page and the FDA notice for D-0870-2026. ConsumerSun does not issue refunds.

How do I know if mine is affected?

Compare Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27 with what you own, along with the product name and the recall date. The official notice is the final list.

Where is the official notice?

This page links to the FDA notice for D-0870-2026. That notice is the final word. ConsumerSun copies the agency record and does not replace it.

Related recalls

Watch my items

Get an email when new recalls are posted for the kinds of things you own. Just your first name and email, nothing else.

Unsubscribe any time with one click. We never share your address.